Search

Your search keyword '"Potts B"' showing total 402 results

Search Constraints

Start Over You searched for: Author "Potts B" Remove constraint Author: "Potts B"
402 results on '"Potts B"'

Search Results

202. Sustaining primary care practice: a model to calculate disease burden and adjust panel size.

203. Dental and skeletal outcomes for Class II surgical-orthodontic treatment: A comparison between novice and experienced clinicians.

204. Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

205. Topical application of L-arginine blocks advanced glycation by ascorbic acid in the lens of hSVCT2 transgenic mice.

206. Method for the direct determination of available carbohydrates in low-carbohydrate products using high-performance anion exchange chromatography.

209. Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.

210. Motor coordination deficits in mice lacking RGS9.

211. Quantitative trait loci for key defensive compounds affecting herbivory of eucalypts in Australia.

212. Accuracy of ED Bedside Ultrasound for Identification of gallstones: retrospective analysis of 575 studies.

213. The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo.

214. Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product.

215. Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor.

216. Early ovule development following self- and cross-pollinations in Eucalyptus globulus Labill. ssp. globulus.

217. Maternal inheritance of the chloroplast genome in Eucalyptus globulus and interspecific hybrids.

218. Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.

219. Chloroplast sharing in the Tasmanian eucalypts.

220. Plant genetics affects arthropod community richness and composition: evidence from a synthetic eucalypt hybrid population.

221. F1 hybrid inviability in eucalyptus: the case of E. ovata x E. globulus.

222. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.

223. Is a calculated total hip BMD of clinical use?

224. ITS sequence data resolve higher level relationships among the eucalypts.

225. Incongruence between chloroplast and species phylogenies in Eucalyptus subgenus Monocalyptus (Myrtaceae).

226. High resolution solution structure of apo calcyclin and structural variations in the S100 family of calcium-binding proteins.

227. Circle size and diameter tilt: a new look at integrality and separability.

228. Chemical shift homology in proteins.

229. 1H NMR assignments of apo calcyclin and comparative structural analysis with calbindin D9k and S100 beta.

230. Maternal monoclonal antibody to the V3 loop alters specificity of the response to a human immunodeficiency virus vaccine.

231. A comparison of genetic information from open-pollinated and control-pollinated progeny tests in two eucalypt species.

232. The structure of calcyclin reveals a novel homodimeric fold for S100 Ca(2+)-binding proteins.

233. Inhibition of the offspring anti-recombinant gp120 antibody response to a human immunodeficiency virus vaccine by maternal immunization in a murine model.

234. Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.

235. Plant hybrid zones as centers of biodiversity: the herbivore community of two endemic Tasmanian eucalypts.

236. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

237. Effects of congenital infection of sheep with border disease virus on myelin proteins.

238. Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3-directed monoclonal antibodies.

239. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells.

240. Primacy of dimensions in color perception.

241. Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization.

242. Phospholipase A2 inhibitors from marine organisms.

243. Relation of plasma and brain concentrations of the anticonvulsant ameltolide to its pharmacologic effects.

244. In vitro inhibition of a variety of human immunodeficiency virus isolates by a broadly reactive, V3-directed heteroconjugate antibody.

245. Replication of HIV-1 and HIV-2 in human bone marrow cultures.

246. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.

247. Recent studies on retrovirus-like particles in Chinese hamster ovary cells.

249. Inheritance of freezing resistance in interspecific F1 hybrids of Eucalyptus.

250. Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsant.

Catalog

Books, media, physical & digital resources